ArticleNature communications2025

Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agents.

Saymon Tejay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.